Intra-arterial clot-dissolving treatment for medium-vessel ischemic stroke

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

RESCUE MeVO is a multicenter, prospective, randomized, open-label, blinded end-point (PROBE) trial that assigns adults with acute ischemic stroke from medium-vessel occlusion or severe stenosis to best medical management alone or to best medical management plus intra-arterial thrombolysis. The intra-arterial treatment uses rhTNK-tPA infused proximal to the lesion for 5–30 minutes, with continuation guided by intraprocedural digital subtraction angiography. Eligible patients are adults with relevant arterial-segment occlusion or ≥70% stenosis, NIHSS scores typically 5–25 (or 3–4 with disabling deficits), and presentation within 24 hours including wake-up strokes, provided imaging shows no large established infarct and good collaterals. The primary outcome is excellent functional recovery (mRS 0–1) at 90 days and safety outcomes include symptomatic intracranial hemorrhage and procedural complications.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age \> 18 years
* Primary medium vessel occlusion (MeVO) or severe stenosis (≥70%) was detected on CTA, MRA, or DSA, involving arterial segments including M2-M3 of the middle cerebral artery (MCA), A1-A2 of the anterior cerebral artery (ACA), P1-P2 of the posterior cerebral artery (PCA), and the anterior inferior cerebellar artery (AICA), posterior inferior cerebellar artery (PICA), and superior cerebellar artery (SCA)
* The clinical symptoms were consistent with MeVO, with a NIHSS score 5 - 25, or an NIHSS score of 3-4 in the presence of disabling neurological deficits (e.g., hemianopia, aphasia, or motor dysfunction)
* Intra-arterial thrombolysis was administered within the following time windows:

  1. Acute ischemic stroke within 24 hours of symptom onset or last known well, including stroke with known onset, wake-up stroke and stroke with unknown onset, with no obvious hypodensity on CT and good collateral circulation on CTA;
  2. Acute ischemic stroke within 24-72 hours of onset, meeting at least one of the following imaging criteria: a.CT or MR perfusion imaging demonstrating target mismatch, defined as an ischemic core volume \<30 mL, a mismatch ratio ≥1.2, and a mismatch volume ≥10 mL.; b.MRI demonstrating DWI-FLAIR mismatch, defined as the presence of acute ischemic lesions on diffusion-weighted imaging (DWI) with no corresponding hyperintense signal on FLAIR, or with FLAIR hyperintense lesions occupying less than one-third of the DWI lesion volume.
* Signed informed consent obtained

Exclusion Criteria:

* Pre-stroke mRS ≥ 2
* Secondary MeVO or severe stenosis caused by endovascular therapy
* Neuroimaging demonstrated intracranial hemorrhage, subarachnoid hemorrhage, or other hemorrhagic disorders
* Non-contrast CT demonstrating a clearly hypodense lesion corresponding to the vascular territory
* Platelet count \<100 × 10⁹/L, known bleeding tendency or coagulation factor deficiency, or oral anticoagulant therapy with an international normalized ratio (INR) \>3.0
* Persistent and uncontrolled hypertension, defined as systolic blood pressure \>185 mmHg or diastolic blood pressure \>110 mmHg
* History of intracranial hemorrhage within the past 3 months, including parenchymal hemorrhage, intraventricular hemorrhage, subarachnoid hemorrhage, epidural hemorrhage, or subdural hemorrhage
* Presence of arteriovenous malformations or brain tumors with mass effect
* Gastrointestinal or urinary tract bleeding, or major surgery within the past 3 months
* Chronic dialysis or severe renal impairment, defined as a glomerular filtration rate (GFR) \<30 mL/min or serum creatinine \>220 μmol/L (2.5 mg/dL)
* Patients with known allergy to thrombolytic agents or their excipients
* Patients with known allergy to iodinated contrast agents or other established contraindications
* Pregnant or current breastfeeding
* Presence of severe systemic comorbidities with a life expectancy of less than 3 months
* Deemed unsuitable for participation by the investigator for any reason

Where it's running

• Fu Yang People's Hospital
  Fuyang, Anhui, China Recruiting
• Lin Quan People's Hospital
  Fuyang, Anhui, China Recruiting
• The Second (Affiliated) Hospital of Anhui Medical University
  Hefei, Anhui, China Recruiting
• Shucheng People's Hospital
  Lu'an, Anhui, China Recruiting
• LiuZhou Worker's Hospital
  Liuzhou, Guangxi, China Recruiting
• Lishui Central Hospital
  Lishui, Zhejiang, China Recruiting

Study contacts

• Principal investigator: Qi Li, professor — The Second Hospital of Anhui Medical University
• Study coordinator: Qi Li, professor
• Email: qili_md@126.com
• Phone: +8618623511778

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Endovascular treatment for stroke beyond 24 hours

  This study is testing whether a specific stroke treatment can help people who have had a stroke more than 24 hours ago feel better and regain independence compared to just receiving standard care.

  Recruiting The Second Hospital of Anhui Medical University · Hefei, Anhui · NCT06959199

• Evaluating the impact of artery calcification on stroke treatment outcomes

  This study is trying to see if the amount of calcium in the arteries affects how well stroke patients do after a specific treatment for blocked blood vessels.

  Recruiting Zhujiang Hospital · Guangzhou, Guangdong · NCT06418698

• Heart assessment to check repeat-stroke risk in people with atrial fibrillation

  This project will test whether detailed heart examinations can find which people with atrial fibrillation who just had an ischemic stroke are at high risk of having another stroke.

  Recruiting Insel Gruppe AG, University Hospital Bern · Bern · NCT06954610

• Portable EEG to triage suspected stroke patients in ambulances

  This trial will test whether a portable dry‑electrode EEG headset (StrokePointer) can detect large vessel occlusion strokes in adults with suspected acute stroke so ambulance crews can take them directly to hospitals that perform thrombectomy.

  Recruiting Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Amsterdam, North Holland · NCT06871969

• Remote ischemic conditioning after aneurysm clipping for ruptured brain aneurysms

  This test tries brief cycles of limb cuff inflation (remote ischemic conditioning) to see if it is safe and helps recovery in adults after surgical clipping of a ruptured brain aneurysm (aneurysmal subarachnoid hemorrhage).

  Recruiting Beijing Tiantan Hospital · Beijing, Beijing Municipality · NCT06819657

• Video call assessment for suspected stroke

  This study tests if using video calls between neurologists and emergency responders can help quickly and accurately assess patients who might be having a stroke.

  Recruiting University of Southern Denmark · Aabenraa, Region Syddanmark · NCT06570681

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.